Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE

<p>Abstract</p> <p>Background</p> <p>The CC chemokine receptors CCR1, CCR2 and CCR5 are critical for the recruitment of mononuclear phagocytes to the central nervous system (CNS) in multiple sclerosis (MS) and other neuroinflammatory diseases. Mononuclear phagocytes are...

Full description

Bibliographic Details
Main Authors: Ericsson-Dahlstrand Anders, Olsson Tomas, Nilsson Maria, Wallström Erik, Lassmann Hans, Berg Anna-Lena, Eltayeb Sana, Sunnemark Dan
Format: Article
Language:English
Published: BMC 2007-05-01
Series:Journal of Neuroinflammation
Online Access:http://www.jneuroinflammation.com/content/4/1/14
id doaj-30c3a816252544e89a8a034416eb3ebb
record_format Article
spelling doaj-30c3a816252544e89a8a034416eb3ebb2020-11-24T23:30:59ZengBMCJournal of Neuroinflammation1742-20942007-05-01411410.1186/1742-2094-4-14Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAEEricsson-Dahlstrand AndersOlsson TomasNilsson MariaWallström ErikLassmann HansBerg Anna-LenaEltayeb SanaSunnemark Dan<p>Abstract</p> <p>Background</p> <p>The CC chemokine receptors CCR1, CCR2 and CCR5 are critical for the recruitment of mononuclear phagocytes to the central nervous system (CNS) in multiple sclerosis (MS) and other neuroinflammatory diseases. Mononuclear phagocytes are effector cells capable of phagocytosing myelin and damaging axons. In this study, we characterize the regional, temporal and cellular expression of CCR1, CCR2 and CCR5 mRNA in the spinal cord of rats with myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (MOG-EAE). While resembling human MS, this animal model allows unique access to CNS-tissue from various time-points of relapsing neuroinflammation and from various lesional stages: early active, late active, and inactive completely demyelinated lesions.</p> <p>Methods</p> <p>The expression of CCR1, CCR2 and CCR5 mRNA was studied with <it>in situ </it>hybridization using radio labelled cRNA probes in combination with immunohistochemical staining for phenotypic cell markers. Spinal cord sections from healthy rats and rats with MOG-EAE (acute phase, remission phase, relapse phase) were analysed. In defined lesion stages, the number of cells expressing CCR1, CCR2 and CCR5 mRNA was determined. Data were statistically analysed by the nonparametric Mann-Whitney U test.</p> <p>Results</p> <p>In MOG-EAE rats, extensive up-regulation of CCR1 and CCR5 mRNA, and moderate up-regulation of CCR2 mRNA, was found in the spinal cord during episodes of active inflammation and demyelination. Double staining with phenotypic cell markers identified the chemokine receptor mRNA-expressing cells as macrophages/microglia. Expression of all three receptors was substantially reduced during clinical remission, coinciding with diminished inflammation and demyelination in the spinal cord. Healthy control rats did not show any detectable expression of CCR1, CCR2 or CCR5 mRNA in the spinal cord.</p> <p>Conclusion</p> <p>Our results demonstrate that the acute and chronic-relapsing phases of MOG-EAE are associated with distinct expression of CCR1, CCR2, and CCR5 mRNA by cells of the macrophage/microglia lineage within the CNS lesions. These data support the notion that CCR1, CCR2 and CCR5 mediate recruitment of both infiltrating macrophages and resident microglia to sites of CNS inflammation. Detailed knowledge of expression patterns is crucial for the understanding of therapeutic modulation and the validation of CCR1, CCR2 and CCR5 as feasible targets for therapeutic intervention in MS.</p> http://www.jneuroinflammation.com/content/4/1/14
collection DOAJ
language English
format Article
sources DOAJ
author Ericsson-Dahlstrand Anders
Olsson Tomas
Nilsson Maria
Wallström Erik
Lassmann Hans
Berg Anna-Lena
Eltayeb Sana
Sunnemark Dan
spellingShingle Ericsson-Dahlstrand Anders
Olsson Tomas
Nilsson Maria
Wallström Erik
Lassmann Hans
Berg Anna-Lena
Eltayeb Sana
Sunnemark Dan
Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE
Journal of Neuroinflammation
author_facet Ericsson-Dahlstrand Anders
Olsson Tomas
Nilsson Maria
Wallström Erik
Lassmann Hans
Berg Anna-Lena
Eltayeb Sana
Sunnemark Dan
author_sort Ericsson-Dahlstrand Anders
title Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE
title_short Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE
title_full Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE
title_fullStr Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE
title_full_unstemmed Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE
title_sort temporal expression and cellular origin of cc chemokine receptors ccr1, ccr2 and ccr5 in the central nervous system: insight into mechanisms of mog-induced eae
publisher BMC
series Journal of Neuroinflammation
issn 1742-2094
publishDate 2007-05-01
description <p>Abstract</p> <p>Background</p> <p>The CC chemokine receptors CCR1, CCR2 and CCR5 are critical for the recruitment of mononuclear phagocytes to the central nervous system (CNS) in multiple sclerosis (MS) and other neuroinflammatory diseases. Mononuclear phagocytes are effector cells capable of phagocytosing myelin and damaging axons. In this study, we characterize the regional, temporal and cellular expression of CCR1, CCR2 and CCR5 mRNA in the spinal cord of rats with myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (MOG-EAE). While resembling human MS, this animal model allows unique access to CNS-tissue from various time-points of relapsing neuroinflammation and from various lesional stages: early active, late active, and inactive completely demyelinated lesions.</p> <p>Methods</p> <p>The expression of CCR1, CCR2 and CCR5 mRNA was studied with <it>in situ </it>hybridization using radio labelled cRNA probes in combination with immunohistochemical staining for phenotypic cell markers. Spinal cord sections from healthy rats and rats with MOG-EAE (acute phase, remission phase, relapse phase) were analysed. In defined lesion stages, the number of cells expressing CCR1, CCR2 and CCR5 mRNA was determined. Data were statistically analysed by the nonparametric Mann-Whitney U test.</p> <p>Results</p> <p>In MOG-EAE rats, extensive up-regulation of CCR1 and CCR5 mRNA, and moderate up-regulation of CCR2 mRNA, was found in the spinal cord during episodes of active inflammation and demyelination. Double staining with phenotypic cell markers identified the chemokine receptor mRNA-expressing cells as macrophages/microglia. Expression of all three receptors was substantially reduced during clinical remission, coinciding with diminished inflammation and demyelination in the spinal cord. Healthy control rats did not show any detectable expression of CCR1, CCR2 or CCR5 mRNA in the spinal cord.</p> <p>Conclusion</p> <p>Our results demonstrate that the acute and chronic-relapsing phases of MOG-EAE are associated with distinct expression of CCR1, CCR2, and CCR5 mRNA by cells of the macrophage/microglia lineage within the CNS lesions. These data support the notion that CCR1, CCR2 and CCR5 mediate recruitment of both infiltrating macrophages and resident microglia to sites of CNS inflammation. Detailed knowledge of expression patterns is crucial for the understanding of therapeutic modulation and the validation of CCR1, CCR2 and CCR5 as feasible targets for therapeutic intervention in MS.</p>
url http://www.jneuroinflammation.com/content/4/1/14
work_keys_str_mv AT ericssondahlstrandanders temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae
AT olssontomas temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae
AT nilssonmaria temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae
AT wallstromerik temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae
AT lassmannhans temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae
AT bergannalena temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae
AT eltayebsana temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae
AT sunnemarkdan temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae
_version_ 1725539341843824640